Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia

Recruiting now

Conditions studied: Trigeminal Neuralgia

In brief

This prospective observational study evaluates the effectiveness and safety of intravenous lacosamide as a rescue treatment for acute pain in patients presenting to the emergency department with trigeminal neuralgia

Key facts

Study ID

NCT06851910

Run by

Hospital Universitari de Bellvitge

People needed

20

Starts

2025-04-21

Expected to finish

2027-05-01

Last updated by the study team

2025-04-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of classical or idiopathic trigeminal neuralgia according to the criteria of the International Classification of Headache Disorders (ICHD-3).
• Age over 18 years.
• Signed informed consent.

You may not qualify if…

• Contraindication for treatment with lacosamide (previous hypersensitivity reaction, known atrioventricular block).
• Mental or psychiatric illness that interferes with the ability to understand and sign the informed consent.
• Language barrier.
• Lack of cooperation.

Where it is running

• Hospital de Bellvitge — L'Hospitalet de Llobregat, Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.